564 Results (Page 20 of 23)
Egypt Markets Research Reports
Egypt Skilled Nursing Market Analysis
Egypt Skilled Nursing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Skilled Nursing is expanding as a result of increasing geriatric population and increasing prevalence of chronic disease. Increasing demand for post-acute are is also fueling the need for specialized and skilled nursing in developing and developed countries. Some of the key players in the global Skilled Nursing Market include Genesis Healthcare Inc., Brookdale Senior Living Inc., Ensign Group Inc., Life Care Centers of America, Kindred Healthcare Inc., Extendicare Inc., Sunrise Senior Living, Atria Senior Living, SavaSeniorCare Administrative Services LLC., and Consulate Health Care.
Egypt Soft Tissue Repair Market Analysis
Egypt Soft Tissue Repair Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Repair is expanding as a result of increasing sports-related injuries and a rising aging population. Increasing demand for non-invasive treatment and advancements in technology are fueling the soft tissue repair market. Some of the key players in the global soft tissue repair market are Smith & Nephew, Arthrex, Stryker Corporation, Baxter, Johnson & Johnson, Medtronic, LifeNet Health, Becton, Dickinson and Company, Integra Life Sciences Corporation, CryoLife, Boston Scientific Corporation, Zimmer Biomet, Baxter International, ACell, Tissue Regenix Group, and Aroa Biosurgery.
Egypt Spinal Implant Market Analysis
Egypt Spinal Implants Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Spinal Implants is expanding as a result of the rising prevalence of Spinal disorders, injuries, and fractures and the rising demand for advanced medical technology. Spinal cord injuries (SCI) are most common during road accidents and all of these spinal disorders are fueling the development of better procedures and devices for the implantation procedure of the spine. Some of the key players in the global Spinal Implants Market include Medtronic, Zimmer Biomet, Alphatec Spine Inc., RTI Surgical, Stryker, Orthofix US LLC, NuVasive Inc., Globus Medical, Aesculap Inc., Apollo Hospitals Enterprise Ltd., Centinel Spine LLC, Premia Spine, Exactech Inc., Aesculap Inc., Lumitex LLC, Life Spine Inc., and Integra LifeSciences
Egypt Teleradiology Market Analysis
Egypt's Teleradiology market size was valued at $7 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2030 and will reach $ 18 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Egypt teleradiology market will grow due to advancements in technology, such as electronic medical records (EMRs) and picture archiving and communication systems (PACS), which have made it easier to transmit and store medical images securely. The key market players are Alborg Laboratories & Radiology Services, Alfa Labs, Cairo Scan Radiology & Labs, Egypt Radiology Group, Ebtisama Radiology, MedMark Teleradiology, Mena Medical Solutions, Radiology Group, Telemedica Egypt and others.
Egypt Patient Engagement Solutions Market Analysis
Egypt's patient engagement solutions market is projected to grow from $47.63 Mn in 2022 to $133.03 Mn by 2030, registering a CAGR of 13.7% during the forecast period of 2022-2030. The main factors driving the growth would be as growing awareness, digital transformation of healthcare and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include AlMokhtabar, Curawella, Siemens Healthineers, Dedalus and Oracle.
Egypt Medical Devices Market Analysis
This report presents a strategic analysis of the Egypt Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Medical Devices Market, offering unmatched value, accuracy and expert insights.
Egypt Artificial Intelligence (AI) in Medical Imaging Market Analysis
Egypt,s Artificial Intelligence (AI) in Medical Imaging market size was valued at $4 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $52 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The demand for advanced medical imaging is increasing in Egypt due to the rising prevalence of chronic diseases and the aging population. Some of the key players in this market are InnoTech Medical Solutions, Nile University's Medical Image and Signal Processing (MISP) Lab, One Way Forward, BrainVISA Technologies, Scintilla for Medical Supplies, BMEYE, Crystal Technology, NewTech Medical Devices, Medispec, Faisal Misbah Mahmoud Radiology Center, and others.
Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy and expert insights.
Egypt Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Egypt Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Egypt Physiotherapy Market Analysis
This report presents a strategic analysis of the Egypt Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Physiotherapy Market, offering unmatched value, accuracy and expert insights.
Egypt Telemedicine Market Analysis
The Egypt telemedicine market size is at around $170 Mn in 2022 and is projected to reach $717 Mn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The driving factors for potential growth in the Egyptian market are the prevalence of chronic diseases, the increasing cost of healthcare, the 5G network, and so on. The telemedicine industry is segmented by component, modality, application, and delivery mode. It also shows the competitive firms like Vezeeta, Clinido, Estshara, Schneider Electric, Siemens AG, and many more.
Egypt Home Healthcare Market Analysis
Egypt's home healthcare market was valued at $1.015 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $2.08 Bn in 2030. The home healthcare market in Egypt has seen significant growth in recent years due to a variety of factors, including an ageing population, increasing rates of chronic diseases, and a growing awareness of the benefits of receiving medical care at home. The market is segmented by device type, service type, and indication type. The key players in Egypt’s home healthcare market are GE Healthcare, Abbott., Philips, Siemens Healthineers, and others.
Egypt Cardiovascular Diseases Therapeutics Market Analysis
The Egypt cardiovascular disease therapeutics market is expected to witness growth from $455 Mn in 2022 to $889 Mn in 2030 with a CAGR of 8.72% for the year 2022-2030. The increasing elderly population in Egypt and the government initiatives like Back to Rhyth and the Nile Heart Challenge to increase awareness about cardiovascular disease in Egypt are the major growth drivers of the market. The Egypt cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Copad Pharma, Menarini Pharmaceutical, and Novartis are the major players in the Egypt cardiovascular disease therapeutics market.
Egypt Depression Therapeutics Market Analysis
The Egypt depression therapeutics market is expected to witness growth from $28 Mn in 2022 to $48 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-2030. The growing incidence of depression in Egypt and its improving health infrastructure has resulted in the growth of the market. The Egypt depression therapeutics market is segmented by drug type, therapies, indication, and by end users. FPi Future Pharmaceutical, Quadri Pharma, and GlaxoSmithKline are the major players in the Egypt depression therapeutics market.
Egypt Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt liver cancer therapeutics market will reach a value of $33.2 Mn from $8.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. The liver cancer therapeutics market in Egypt is dominated by a few domestic pharmaceutical companies such as Pharco Pharmaceuticals, EIPICO, and Memac Pharma. The liver cancer therapeutics market in Egypt is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Egypt Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Lung Cancer Therapeutics Market will reach a value of $174 Mn from $83 Mn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in Egypt is dominated by a few domestic pharmaceutical companies such as EIPICO, Pharco Pharmaceuticals, and El-Nasr Pharmaceutical Chemicals. The Lung Cancer Therapeutics Market in Egypt is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Egypt lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Egypt Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Oncology Therapeutics Market will reach a value of $1.1 Bn from $0.51 Bn in 2022, growing at a CAGR of 9.9% during 2022-2030. The Oncology Therapeutics Market in Egypt is dominated by a few domestic pharmaceutical companies such as Pharco, EIPICO, and Amoun Pharmaceutical. The Oncology Therapeutics Market in Egypt is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Egypt Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Egypt Cardiac Surgery Instruments Market Analysis
The Egypt Cardiac Surgery Instruments Market is expected to witness growth from $6 Mn in 2022 to $11 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Egypt, cardiac conditions like coronary artery disease and heart failure are extremely prevalent. The need for the instruments used in these procedures is growing as a consequence of the rise in cardiac surgeries. The market is segmented by type, application and by end user. Some key players in this market include JK Medirise, EGMED, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Egypt Anti Aging Therapeutics Market Analysis
Egypt anti-aging therapeutics market is expected to witness growth from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. Egypt’s rising elderly population and their subsequent demand for innovative anti-aging treatments are responsible for the growth of the market during the forecast period. The Egypt anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are CEB, Botogenix, and Intervene Immune.
Egypt Biomaterials in Healthcare Market Analysis
The Egypt Biomaterials in Healthcare Market is expected to witness growth from $438 Mn in 2022 to $1311 Mn in 2030 with a CAGR of 14.70% for the forecasted year 2022-2030. As Egypt's population ages, there is a growing demand for biomaterials to treat conditions like osteoarthritis, spine issues, and cardiovascular disease. The market is segmented by type and by application. Some key players in this market include: MedNotch, Procare, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Egypt Healthcare Financial Analytics Market Analysis
The Egypt Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Egypt’s Healthcare Financial Analytics market will grow as the rising prevalence of chronic diseases in Egypt, such as diabetes, cancer, and cardiovascular disease. The key market players are Clinsoft, Infrahealth, Naseej, Medisoft, Redcliffe Life Sciences, and others.
Egypt Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Liver Disease Therapeutics market will reach a value of $113 Mn from $65 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Egypt is dominated by domestic pharmaceutical companies such as Pharco Pharmaceuticals, Delta Pharma, and EIPICO. The Liver Disease Therapeutics market in Egypt is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Egypt Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Egypt Neurology Devices Market Analysis
The Egypt Neurology Device Market is expected to witness growth from $35 Mn in 2022 to $72 Mn in 2030 with a CAGR of 9.30% for the forecasted year 2022-2030. There is a rising need for neurology devices in Egypt due to the frequency of neurological disorders such as stroke, epilepsy, Parkinson's disease, and multiple sclerosis. The market is segmented by product type and by the end user. Major Key players in Malaysia's neurology devices market include Wassenburg Medical, EMG-EP Technologies, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories.
Egypt Neurology Clinical Trials Market Analysis
The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the increasing involvement from both global and local companies, a supportive regulatory environment and a growing pool of qualified professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Minapharm Pharmaceuticals & EIPICO.
Egypt Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt infectious disease therapeutics market will reach a value of $528.93 Mn from $335.64 Mn in 2022, growing at a CAGR of 5.9% during 2022-2030. The Infectious Disease Therapeutics in Egypt is dominated by a few domestic pharmaceutical companies such as EIPICO, Pharco Pharmaceuticals and Memphis Pharmaceutical. The Infectious Disease Therapeutics market in Egypt is segmented into different therapeutic areas and different diseases type. The major factors affecting the Egypt infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various of areas of Egypt.
